Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4.

Ruggenenti P, Gentile G, Perico N, Perna A, Barcella L, Trillini M, Cortinovis M, Ferrer Siles CP, Reyes Loaeza JA, Aparicio MC, Fasolini G, Gaspari F, Martinetti D, Carrara F, Rubis N, Prandini S, Caroli A, Sharma K, Antiga L, Remuzzi A, Remuzzi G; SIRENA 2 Study Group.

Clin J Am Soc Nephrol. 2016 May 6;11(5):785-94. doi: 10.2215/CJN.09900915. Epub 2016 Feb 22.

2.

Percutaneous transhepatic biliary drainage in an infant with obstructive jaundice caused by neuroblastoma.

Saettini F, Agazzi R, Giraldi E, Foglia C, Cavalleri L, Morali L, Fasolini G, Spotti A, Provenzi M.

Pediatr Hematol Oncol. 2015 Apr;32(3):223-8. doi: 10.3109/08880018.2014.981901. Epub 2014 Dec 31.

PMID:
25551550
3.

Jellyfish in the heart.

Dieli M, Simon C, Brucato A, Pedrotti P, Colombo T, Moreo A, Fasolini G, Gori M, Gianatti A, Medolago G, Ferrazzi P.

Circulation. 2013 Feb 12;127(6):e443-5. doi: 10.1161/CIRCULATIONAHA.112.116848. No abstract available. Erratum in: Circulation. 2013 Apr 16;127(15):e551. Gori, Maurizio [corrected to Gori, Mauro].

PMID:
23401118
4.

Extensive arterial tortuosity and severe aortic dilation in a newborn with an EFEMP2 mutation.

Iascone M, Sana ME, Pezzoli L, Bianchi P, Marchetti D, Fasolini G, Sadou Y, Locatelli A, Fabiani F, Mangili G, Ferrazzi P.

Circulation. 2012 Dec 4;126(23):2764-8. doi: 10.1161/CIRCULATIONAHA.112.119883. No abstract available.

PMID:
23212998
5.

Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients.

Caroli A, Antiga L, Conti S, Sonzogni A, Fasolini G, Ondei P, Perico N, Remuzzi G, Remuzzi A.

Am J Pathol. 2011 Aug;179(2):619-27. doi: 10.1016/j.ajpath.2011.04.036. Epub 2011 Jun 17.

6.

Sirolimus therapy to halt the progression of ADPKD.

Perico N, Antiga L, Caroli A, Ruggenenti P, Fasolini G, Cafaro M, Ondei P, Rubis N, Diadei O, Gherardi G, Prandini S, Panozo A, Bravo RF, Carminati S, De Leon FR, Gaspari F, Cortinovis M, Motterlini N, Ene-Iordache B, Remuzzi A, Remuzzi G.

J Am Soc Nephrol. 2010 Jun;21(6):1031-40. doi: 10.1681/ASN.2009121302. Epub 2010 May 13.

7.

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide.

Caroli A, Antiga L, Cafaro M, Fasolini G, Remuzzi A, Remuzzi G, Ruggenenti P.

Clin J Am Soc Nephrol. 2010 May;5(5):783-9. doi: 10.2215/CJN.05380709. Epub 2010 Feb 25.

8.

Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.

Antiga L, Piccinelli M, Fasolini G, Ene-Iordache B, Ondei P, Bruno S, Remuzzi G, Remuzzi A.

Clin J Am Soc Nephrol. 2006 Jul;1(4):754-60. Epub 2006 Jun 14.

9.

Chest trauma associated with heart dislodgement.

Fumagalli R, Donatelli F, Fasolini G.

J Trauma. 2006 May;60(5):1114-6. No abstract available.

PMID:
16688079
10.

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.

Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH.

Kidney Int. 2005 Jul;68(1):206-16.

11.

Post-transplant renal artery stenosis: the hemodynamic response to revascularization.

Ruggenenti P, Mosconi L, Bruno S, Remuzzi A, Sangalli F, Lepre MS, Agazzi R, Nani R, Fasolini G, Remuzzi G.

Kidney Int. 2001 Jul;60(1):309-18.

Supplemental Content

Loading ...
Support Center